Doctor profile · Federal record
Dr. Matthew Innes, M.D.
Dermatology Physician (CMS: Dermatology) · Layton, UT
- NPI 1679952212
- Accepts Medicare
- 11 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
2121 N 1700 W
Layton, UT 840418803
(801) 773-4840
fax (801) 525-8151 - Mailing address
-
Po Box 337
Layton, UT 840410337
Credentials & registration
- NPI registered
- May 2015 — 11 yrs on file
- Profile last updated
- June 13, 2022
- Year of graduation
- 2015 — 11 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Utah #11240952-1205
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1679952212. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,552
Distinct HCPCS
10
Medicare allowed
$95,858
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 444 | 93 | $6 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 166 | 117 | $121 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 161 | 137 | $86 | |
17000 |
Destruction of precancer skin growth, 1 growth | 149 | 134 | $56 | |
11102 |
Biopsy of related skin growth, first growth | 109 | 97 | $91 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 86 | 86 | $106 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 85 | 16 | $1 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 81 | 73 | $53 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 63 | 63 | $155 | |
11103 |
Biopsy of related skin growth, each additional growth | 56 | 33 | $47 |
In context: peer comparison
Among 6 peers in Layton Dermatology Physician, average services per provider: 191. This provider delivers 8.1× the peer median.Open Payments
Industry payments received
All-time total
$1,528
Transactions
103
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | 24 | $320.66 | |
| Abbvie INC. | 34 | $293.26 | |
| Novartis Pharmaceuticals Corporation | 12 | $160.69 | |
| Janssen Biotech, INC. | 5 | $150.37 | |
| Ucb, INC. | 4 | $105.91 | |
| Leo Pharma INC. | 4 | $90.66 | |
| Lilly USA, LLC | 3 | $65.11 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $50.38 | |
| Pfizer INC. | 2 | $45.23 | |
| Genzyme Corporation | 2 | $42.08 | |
| Organon LLC | 3 | $36.81 | |
| Galderma Laboratories, L.P. | 2 | $36.72 | |
| Dermavant Sciences, INC. | 2 | $32.27 | |
| Incyte Corporation | 2 | $28.10 | |
| Biofrontera INC. | 1 | $24.59 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
387
Patients
214
Total drug cost
$17,551
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Clobetasol Propionate | Generic | 78 | 45 | $3,832 |
| Triamcinolone Acetonide | Generic | 77 | 48 | $684 |
| Ketoconazole | Generic | 42 | 26 | $1,108 |
| Fluorouracil | Generic | 35 | 32 | $2,997 |
| Hydrocortisone | Generic | 31 | 18 | $276 |
| Tacrolimus | Generic | 31 | 22 | $4,568 |
| Mupirocin | Generic | 29 | 23 | $253 |
| Doxycycline Monohydrate | Generic | 15 | 0 | $702 |
| Metronidazole | Generic | 13 | 0 | $973 |
| Terbinafine Hcl | Generic | 13 | 0 | $361 |
Frequently asked questions
What is Dr. Matthew Innes's medical specialty?
Dr. Matthew Innes practices Dermatology Physician in Layton, UT.
Where does Dr. Matthew Innes practice?
Dr. Matthew Innes practices at 2121 N 1700 W, Layton, UT 840418803. Office phone: 8017734840.
What is Dr. Matthew Innes's NPI?
Dr. Matthew Innes's National Provider Identifier (NPI) is 1679952212, issued by NPPES.
Does Dr. Matthew Innes accept Medicare assignment?
Yes. Dr. Matthew Innes accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Matthew Innes commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99214); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.